dehydroepiandrosterone has been researched along with Leiomyoma in 10 studies
Dehydroepiandrosterone: A major C19 steroid produced by the ADRENAL CORTEX. It is also produced in small quantities in the TESTIS and the OVARY. Dehydroepiandrosterone (DHEA) can be converted to TESTOSTERONE; ANDROSTENEDIONE; ESTRADIOL; and ESTRONE. Most of DHEA is sulfated (DEHYDROEPIANDROSTERONE SULFATE) before secretion.
dehydroepiandrosterone : An androstanoid that is androst-5-ene substituted by a beta-hydroxy group at position 3 and an oxo group at position 17. It is a naturally occurring steroid hormone produced by the adrenal glands.
Leiomyoma: A benign tumor derived from smooth muscle tissue, also known as a fibroid tumor. They rarely occur outside of the UTERUS and the GASTROINTESTINAL TRACT but can occur in the SKIN and SUBCUTANEOUS TISSUE, probably arising from the smooth muscle of small blood vessels in these tissues.
| Excerpt | Relevance | Reference |
|---|---|---|
| "The purposes of this study were to investigate the effect of a superactive agonistic analog of gonadotropin-releasing hormone, nafarelin, on uterine leiomyomas and to assess the use of magnetic resonance imaging in monitoring uterine and myoma size." | 7.67 | Use of an agonistic analog of gonadotropin-releasing hormone (nafarelin) to treat leiomyomas: assessment by magnetic resonance imaging. ( Andreyko, JL; Blumenfeld, Z; Hricak, H; Jaffe, RB; Marshall, LA; Monroe, SE, 1988) |
| "The purposes of this study were to investigate the effect of a superactive agonistic analog of gonadotropin-releasing hormone, nafarelin, on uterine leiomyomas and to assess the use of magnetic resonance imaging in monitoring uterine and myoma size." | 3.67 | Use of an agonistic analog of gonadotropin-releasing hormone (nafarelin) to treat leiomyomas: assessment by magnetic resonance imaging. ( Andreyko, JL; Blumenfeld, Z; Hricak, H; Jaffe, RB; Marshall, LA; Monroe, SE, 1988) |
| "The presence of uterine leiomyomas correlates with an increase in urinary concentrations of estrogens and androgens, and it appears to be caused by a decrease in patients' metabolism of steroids." | 1.32 | Endogenous urinary steroids in premenopausal women with uterine leiomyomas. ( Bai, SW; Chung, BC; Jung, BH, 2004) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 7 (70.00) | 18.7374 |
| 1990's | 2 (20.00) | 18.2507 |
| 2000's | 1 (10.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| GIORGI, EP | 1 |
| JANATA, J | 1 |
| STARKA, L | 1 |
| WARREN, JC | 1 |
| FRENCH, AP | 1 |
| Jung, BH | 1 |
| Bai, SW | 1 |
| Chung, BC | 1 |
| Frigo, P | 1 |
| Eppel, W | 1 |
| Asseryanis, E | 1 |
| Sator, M | 1 |
| Golaszewski, T | 1 |
| Gruber, D | 1 |
| Lang, C | 1 |
| Huber, J | 1 |
| Murphy, AA | 1 |
| Kettel, LM | 1 |
| Morales, AJ | 1 |
| Roberts, VJ | 1 |
| Yen, SS | 1 |
| Andreyko, JL | 1 |
| Blumenfeld, Z | 1 |
| Marshall, LA | 1 |
| Monroe, SE | 1 |
| Hricak, H | 1 |
| Jaffe, RB | 1 |
| Aakvaag, A | 1 |
| Fylling, P | 1 |
| Miasnikov, LA | 1 |
| Vinogradova, DA | 1 |
| Marsiletti, GC | 1 |
| Lago, E | 1 |
| Trial | Phase | Enrollment | Study Type | Start Date | Status | ||
|---|---|---|---|---|---|---|---|
| The Effect of Vaginal Mifepristone on Reduction of Uterine Fibroids Size and the Symptoms Associated With the Fibroids - Pilot Study (Phase IIa)[NCT00881140] | Phase 2 | 30 participants (Actual) | Interventional | 2009-04-30 | Completed | ||
| [information is prepared from clinicaltrials.gov, extracted Sep-2024] | |||||||
1 trial available for dehydroepiandrosterone and Leiomyoma
| Article | Year |
|---|---|
The effects of hormone substitution in depot form on the uterus in a group of 50 perimenopausal women--a vaginosonographic study.
Topics: Dehydroepiandrosterone; Delayed-Action Preparations; Drug Combinations; Endometrium; Estradiol; Estr | 1995 |
9 other studies available for dehydroepiandrosterone and Leiomyoma
| Article | Year |
|---|---|
THE DETERMINATION OF STEROIDS IN CYST FLUID FROM HUMAN POLYCYSTIC OVARIES.
Topics: Androgens; Chromatography; Cyst Fluid; Cysts; Dehydroepiandrosterone; Endometriosis; Estradiol; Estr | 1963 |
EFFECT OF CORTISOL ON THE PRODUCTION OF OVARIAN ANDROGENS.
Topics: 17-Ketosteroids; Adrenocorticotropic Hormone; Amenorrhea; Androgens; Biomedical Research; Dehydroepi | 1964 |
DISTRIBUTION OF STEROID SULFATASE IN HUMAN TISSUES.
Topics: Abnormalities, Severe Teratoid; Adipose Tissue; Anencephaly; Animals; Carbon Isotopes; Cattle; Corpu | 1965 |
Endogenous urinary steroids in premenopausal women with uterine leiomyomas.
Topics: Adult; Androgens; Androstenols; Androsterone; Case-Control Studies; Corticosterone; Cortodoxone; Deh | 2004 |
Regression of uterine leiomyomata in response to the antiprogesterone RU 486.
Topics: Adolescent; Adult; Androstenedione; Bone Density; Dehydroepiandrosterone; Dehydroepiandrosterone Sul | 1993 |
Use of an agonistic analog of gonadotropin-releasing hormone (nafarelin) to treat leiomyomas: assessment by magnetic resonance imaging.
Topics: Adult; Androstenedione; Dehydroepiandrosterone; Dehydroepiandrosterone Sulfate; Drug Evaluation; Est | 1988 |
A method for the simultaneous determination of progesterone, androstenedione, testosterone and dehydroepiandrosterone sulphate in biological fluids. Its application in the analysis of venous plasma and cyst fluid from human ovaries in situ.
Topics: 17-Ketosteroids; Adult; Amenorrhea; Androgens; Chromatography, Gas; Dehydroepiandrosterone; Endometr | 1968 |
[Estrogens and androgens in dyshormonal cardiopathy and coronary atherosclerosis in women].
Topics: 17-Ketosteroids; Adult; Androgens; Androsterone; Arteriosclerosis; Chromatography, Thin Layer; Coron | 1971 |
[Problems of therapy of uterine myofibroma with special reference to the hormonal and opotherapeutic opotherapeutic treatment].
Topics: Age Factors; Breast; Dehydroepiandrosterone; Female; Humans; Leiomyoma; Tissue Extracts; Uterine Neo | 1971 |